UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases

Cancer chemotherapy and pharmacology, 2014-11, Vol.74 (5), p.1023-1028

2014

Volltextzugriff (PDF)

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant

Cancer cell, 2011-05, Vol.19 (5), p.679-690

2011

Volltextzugriff (PDF)

1172 SAIL66, a next generation of T cell engager targeting CLDN6, potentiates efficacy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1292-A1292

2023

Volltextzugriff (PDF)

Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance

Cancer letters, 2014-09, Vol.351 (2), p.215-221

2014

Volltextzugriff (PDF)

Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer

Molecular cancer therapeutics, 2014-12, Vol.13 (12), p.2910-2918

2014

Volltextzugriff (PDF)

Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple Myeloma

Molecular cancer therapeutics, 2019-09, Vol.18 (9), p.1555-1564

2019

Volltextzugriff (PDF)

Abstract 1886: Anti -GPRC5D/CD3 T cell-redirecting bispecific antibody with potent in vitro and in vivo antitumor efficacy against multiple myeloma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1886-1886

2021

Volltextzugriff (PDF)

Abstract 773: Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.773-773

2015

Volltextzugriff (PDF)

Abstract 1239: SAIL66, a next generation T cell engager targeting CLDN6, potentiates efficacy by binding to CD3/CD137

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1239-1239

2024

Volltextzugriff (PDF)

Abstract 754: Selective ALK inhibitor alectinib (CH5424802/RO5424802) with potent antitumor activity in models of crizotinib resistance, including intracranial metastases

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.754-754

2014

Volltextzugriff (PDF)

Abstract 3853: Unique pattern of copy number changes including chromothripsis in pulmonary adenocarcinoma with EML4-ALK fusion

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3853-3853

2015

Volltextzugriff (PDF)

A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line

Journal of thoracic oncology, 2014-11, Vol.9 (11), p.1638-1646

2014

Volltextzugriff (PDF)

Abstract 2192: A novel mechanism of EML4-ALK rearrangement in a patient-derived cell line and its tumor growth inhibition by an ALK inhibitor CH5424802

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2192-2192

2013

Volltextzugriff (PDF)

Abstract 3559: A new selective ALK inhibitor CH5424802 shows potent efficacy against ALK-positive cancers including the gatekeeper mutant-driven tumors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3559-3559

2011

Volltextzugriff (PDF)

Selection of a histidine auxotrophic Marchantia polymorpha strain with an auxotrophic selective marker

Plant Biotechnology, 2022, pp.22.0810a

2022

Volltextzugriff (PDF)

Selection of a histidine auxotrophic Marchantia polymorpha strain with an auxotrophic selective marker

Plant Biotechnology, 2022/12/25, Vol.39(4), pp.345-354

2022

Volltextzugriff (PDF)

Petri net representation and reachability analysis of 0–1 integer linear programming problems

Information sciences, 2017-08, Vol.400-401, p.157-172

2017

Volltextzugriff (PDF)

Delayed Brachial Plexus Palsy after Clavicular Fracture

Internal Medicine, 2021/08/01, Vol.60(15), pp.2511-2512

2021

Volltextzugriff (PDF)

Transient Peri-ictal Edema around Calcified Neurocysticercosis Lesions

Internal Medicine, 2020/08/01, Vol.59(15), pp.1921-1922

2020

Volltextzugriff (PDF)

Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study

Movement disorders, 2021-11, Vol.36 (11), p.2461-2463

2021

Volltextzugriff (PDF)

Recovery after Prolonged Disturbance of Consciousness and Repeated Cerebral Perfusion Changes in Neuronal Intranuclear Inclusion Disease

Internal Medicine, 2024/01/15, Vol.63(2), pp.333-336

2024

Volltextzugriff (PDF)

Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report

Internal Medicine, 2024, pp.3392-23

2024

Volltextzugriff (PDF)

Outcomes of gastrointestinal cancer surgeries in Parkinson's disease patients: A nationwide study

Parkinsonism & related disorders, 2022-03, Vol.96, p.45-49

2022

Volltextzugriff (PDF)

Management of elderly-onset epilepsy: A narrative review

Epilepsy & Seizure, 2023, Vol.15(1), pp.104-116

2023

Volltextzugriff (PDF)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302

Liver cancer (Basel ), 2022-09, Vol.11 (5), p.440-450

2022

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Humans
(19)
Male
(12)
Oncology
(10)
Adult
(9)
Female
(8)
Middle Aged
(8)
Neurosciences & Neurology
(7)
Clinical Neurology
(6)
Animals
(5)
Cell Line, Tumor
(5)
Aged
(4)
Carbazoles - Pharmacology
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)
Lung Neoplasms - Genetics
(4)
Mice
(4)
Piperidines - Pharmacology
(4)
Prospective Studies
(4)
Protein Kinase Inhibitors - Pharmacology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant

1172 SAIL66, a next generation of T cell engager targeting CLDN6, potentiates efficacy

Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance

Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer

Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple Myeloma

Abstract 1886: Anti -GPRC5D/CD3 T cell-redirecting bispecific antibody with potent in vitro and in vivo antitumor efficacy against multiple myeloma

Abstract 773: Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancers

Abstract 1239: SAIL66, a next generation T cell engager targeting CLDN6, potentiates efficacy by binding to CD3/CD137

Abstract 754: Selective ALK inhibitor alectinib (CH5424802/RO5424802) with potent antitumor activity in models of crizotinib resistance, including intracranial metastases

Abstract 3853: Unique pattern of copy number changes including chromothripsis in pulmonary adenocarcinoma with EML4-ALK fusion

A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line

Abstract 2192: A novel mechanism of EML4-ALK rearrangement in a patient-derived cell line and its tumor growth inhibition by an ALK inhibitor CH5424802

Abstract 3559: A new selective ALK inhibitor CH5424802 shows potent efficacy against ALK-positive cancers including the gatekeeper mutant-driven tumors

Selection of a histidine auxotrophic Marchantia polymorpha strain with an auxotrophic selective marker

Selection of a histidine auxotrophic Marchantia polymorpha strain with an auxotrophic selective marker

Petri net representation and reachability analysis of 0–1 integer linear programming problems

Delayed Brachial Plexus Palsy after Clavicular Fracture

Transient Peri-ictal Edema around Calcified Neurocysticercosis Lesions

Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study

Recovery after Prolonged Disturbance of Consciousness and Repeated Cerebral Perfusion Changes in Neuronal Intranuclear Inclusion Disease

Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report

Outcomes of gastrointestinal cancer surgeries in Parkinson's disease patients: A nationwide study

Management of elderly-onset epilepsy: A narrative review

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302

Suchergebnisse filtern